$ELRE Balance Sheet | Understand Stock

$ELRE

$1.00 +$0.05 (5.6%) Close

$ELRE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In USD, except per-share amounts

	Q1 FY2027 As of Jun 30, 2026	Q4 FY2026 As of Mar 31, 2026	Q3 FY2026 As of Dec 31, 2025	Q2 FY2026 As of Sep 30, 2025	Q1 FY2026 As of Jun 30, 2025	Q4 FY2025 As of Mar 31, 2025	Q3 FY2025 As of Dec 31, 2024	Q2 FY2025 As of Sep 30, 2024	Q1 FY2025 As of Jun 30, 2024	Q4 FY2024 As of Mar 31, 2024	Q3 FY2024 As of Dec 31, 2023	Q2 FY2024 As of Sep 30, 2023	Q1 FY2024 As of Jun 30, 2023	Q4 FY2023 As of Mar 31, 2023	Q3 FY2023 As of Dec 31, 2022	Q2 FY2023 As of Sep 30, 2022	Q1 FY2023 As of Jun 30, 2022	Q4 FY2022 As of Mar 31, 2022	Q3 FY2022 As of Dec 31, 2021	Q2 FY2022 As of Sep 30, 2021
Current Assets
Cash and cash equivalents
Cash and cash equivalents
Other receivables
Total current Assets
Operating lease right of use asset, net
Total non-current assets
Total Assets
Current liabilities
Borrowing
Accrued interest - related party
Accounts payable and accrued liabilities
Other payables
Short-term loan - related party

Accrued interest - related party
Operating lease liabilities - current
Due to related party
Other payable
Total Current Liabilities
Non-current liabilities
Operating lease liabilities - noncurrent
Total Non-current Liabilities
Total Liabilities
Commitment and Contingency
Stockholders' Deficit
Common stock, ($0.001 par value, 3,000,000,000 shares authorized, 121,983,993 shares issued and outstanding as of June 30, 2026 and March 31, 2026)
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total Stockholders' Deficit
Total Liabilities and Stockholders' Deficit
Total Liabilities and Stockholders' Deficit

Comments